Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

被引:4
|
作者
Noort, Willy A. [1 ]
Groen, Richard W. J. [1 ]
Raymakers, Reinier [1 ]
Aalders, Linda [1 ]
Hofhuis, Frans M. [1 ]
Van Kessel, Berris [1 ]
Van Velzen, Jeroen F. [1 ]
de Bruijn, Joost [2 ]
Yuan, Huipin [3 ]
van Bueren, Jeroen Lammerts [4 ]
Bloem, Andries C. [1 ]
Parren, Paul W. H. I. [4 ]
Lokhorst, Henk [1 ]
Mutis, Tuna [1 ]
Martens, Anton C. M. [1 ]
机构
[1] UMC Utrecht, Utrecht, Netherlands
[2] Xpand Biotechnol, Bilthoven, Netherlands
[3] Xpand Biotechnol BV, Bilthoven, Netherlands
[4] Genmab BV, Utrecht, Netherlands
关键词
D O I
10.1182/blood.V120.21.940.940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
940
引用
收藏
页数:2
相关论文
共 41 条
  • [41] A Single Dose of a Novel Anti-Human Short Half-Life Engineered CD45-Targeted Antibody-Drug Conjugate (ADC) Is Cytoreductive on Patient-Derived Tumors and Extends Survival Beyond Standards of Care in Multiple Pre-Clinical Models of Hematologic Malignancy
    Proctor, Jennifer L.
    Gillard, Geoffrey O.
    Mikse, Oliver
    Lanieri, Leanne
    Lamothe, Tahirih L.
    Brooks, Melissa L.
    Kien, Lena
    McDonough, Sean M.
    Bhat, Anjali
    Palchaudhuri, Rahul
    Bhattarai, Prashant Raj
    Sarma, Ganapathy N.
    Jain, Nidhi
    McDonagh, Charlotte F.
    Boitano, Anthony E.
    Cooke, Michael P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S96 - S96